Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1

View ORCID ProfileKamil Nosol, View ORCID ProfileKsenija Romane, View ORCID ProfileRossitza N. Irobalieva, Amer Alam, View ORCID ProfileJulia Kowal, View ORCID ProfileNaoya Fujita, and View ORCID ProfileKaspar P. Locher
  1. aInstitute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland;
  2. bThe Hormel Institute, University of Minnesota, Austin, MN 55912;
  3. cThe Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, 135-8550 Koto-ku, Tokyo, Japan

See allHide authors and affiliations

PNAS October 20, 2020 117 (42) 26245-26253; first published October 5, 2020; https://doi.org/10.1073/pnas.2010264117
Kamil Nosol
aInstitute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kamil Nosol
Ksenija Romane
aInstitute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ksenija Romane
Rossitza N. Irobalieva
aInstitute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rossitza N. Irobalieva
Amer Alam
aInstitute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland;
bThe Hormel Institute, University of Minnesota, Austin, MN 55912;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Kowal
aInstitute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia Kowal
Naoya Fujita
cThe Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, 135-8550 Koto-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Naoya Fujita
Kaspar P. Locher
aInstitute of Molecular Biology and Biophysics, ETH Zürich, 8093 Zürich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kaspar P. Locher
  • For correspondence: locher@mol.biol.ethz.ch
  1. Edited by Richard Callaghan, Australian National University, Canberra, ACT, Australia, and accepted by Editorial Board Member Axel T. Brunger September 8, 2020 (received for review May 21, 2020)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

ABCB1 is a membrane transport protein that protects cells from toxic compounds. At the same time, it limits the uptake of orally administered drugs and contributes to multidrug resistance in cancer cells. Small-molecule inhibitors of ABCB1 could alleviate these negative effects, but their development requires detailed insight into how such compounds interfere with ABCB1-catalyzed drug extrusion. Our study shows how ABCB1 inhibitors bind in pairs and can block the function of the transporter by interacting with structural features that are important for its transport function. Our results therefore provide insight into the mechanism of ABCB1 and will be valuable for the development of more effective inhibitors.

Abstract

ABCB1 detoxifies cells by exporting diverse xenobiotic compounds, thereby limiting drug disposition and contributing to multidrug resistance in cancer cells. Multiple small-molecule inhibitors and inhibitory antibodies have been developed for therapeutic applications, but the structural basis of their activity is insufficiently understood. We determined cryo-EM structures of nanodisc-reconstituted, human ABCB1 in complex with the Fab fragment of the inhibitory, monoclonal antibody MRK16 and bound to a substrate (the antitumor drug vincristine) or to the potent inhibitors elacridar, tariquidar, or zosuquidar. We found that inhibitors bound in pairs, with one molecule lodged in the central drug-binding pocket and a second extending into a phenylalanine-rich cavity that we termed the “access tunnel.” This finding explains how inhibitors can act as substrates at low concentration, but interfere with the early steps of the peristaltic extrusion mechanism at higher concentration. Our structural data will also help the development of more potent and selective ABCB1 inhibitors.

  • ABC transporter
  • ABCB1
  • P-glycoprotein
  • single-particle cryoelectron microscopy
  • structure

Footnotes

  • ↵1To whom correspondence may be addressed. Email: locher{at}mol.biol.ethz.ch.
  • Author contributions: K.N. and K.P.L. designed research; K.N., K.R., R.N.I., J.K., and K.P.L. performed research; N.F. contributed new reagents/analytic tools; K.N., K.R., A.A., and K.P.L. analyzed data; and K.N. and K.P.L. wrote the paper.

  • The authors declare no competing interest.

  • This article is a PNAS Direct Submission. R.C. is a guest editor invited by the Editorial Board.

  • This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2010264117/-/DCSupplemental.

Data Availability.

Data associated with this research have been deposited in the Electron Microscopy Data Bank (EMDB) (EMD-11666, EMD-11667, EMD-11670, EMD-11671, EMD-11672). Coordinates for deposited models are available at the Protein Data Bank with IDs: 7A65 (drug-free ABCB1–MRK16-Fab), 7A69 (vincristine-bound ABCB1–MRK16-Fab), 7A6C (elacridar-bound ABCB1–MRK16-Fab), 7A6E (tariquidar-bound ABCB1–MRK16-Fab), and 7A6F (zosuquidar-bound ABCB1–MRK16-Fab).

Published under the PNAS license.

View Full Text

References

  1. ↵
    1. M. F. Fromm
    , Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci. 25, 423–429 (2004).
    OpenUrlCrossRefPubMed
  2. ↵
    1. D. S. Wishart et al.
    , Drugbank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34, D668–D672 (2006).
    OpenUrlCrossRefPubMed
  3. ↵
    1. K. M. Giacomini et al.; International Transporter Consortium
    , Membrane transporters in drug development. Nat. Rev. Drug Discov. 9, 215–236 (2010).
    OpenUrlCrossRefPubMed
  4. ↵
    1. R. W. Robey et al.
    , Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat. Rev. Cancer 18, 452–464 (2018).
    OpenUrlCrossRefPubMed
  5. ↵
    1. E. Martino et al.
    , Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. Bioorg. Med. Chem. Lett. 28, 2816–2826 (2018).
    OpenUrl
  6. ↵
    1. X. Zhou,
    2. Z. Xu,
    3. A. Li,
    4. Z. Zhang,
    5. S. Xu
    , Double-sides sticking mechanism of vinblastine interacting with α,β-tubulin to get activity against cancer cells. J. Biomol. Struct. Dyn. 37, 4080–4091 (2019).
    OpenUrl
  7. ↵
    1. R. C. Wang et al.
    , Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents. PLoS One 12, e0182400 (2017).
    OpenUrl
  8. ↵
    1. J. Zhou
    1. E. Crowley,
    2. C. A. McDevitt,
    3. R. Callaghan,
    “Generating inhibitors of P-Glycoprotein: Where to, now?” in Methods in Molecular Biology, J. Zhou, Ed. (Humana Press, 2010), pp. 405–432.
  9. ↵
    1. J. Robert,
    2. C. Jarry
    , Multidrug resistance reversal agents. J. Med. Chem. 46, 4805–4817 (2003).
    OpenUrlCrossRefPubMed
  10. ↵
    1. F. Hyafil,
    2. C. Vergely,
    3. P. Du Vignaud,
    4. T. Grand-Perret
    , In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 53, 4595–4602 (1993).
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. M. Roe et al.
    , Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. Bioorg. Med. Chem. Lett. 9, 595–600 (1999).
    OpenUrlCrossRefPubMed
  12. ↵
    1. L. D. Cripe et al.
    , Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: A randomized, placebo-controlled trial of the eastern cooperative oncology group 3999. Blood 116, 4077–4085 (2010).
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. J. P. Bankstahl et al.
    , Tariquidar and elacridar are dose-dependently transported by P-glycoprotein and bcrp at the blood-brain barrier: A small-animal positron emission tomography and in vitro study. Drug Metab. Dispos. 41, 754–762 (2013).
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. E. B. Mechetner,
    2. I. B. Roninson
    , Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. U.S.A. 89, 5824–5828 (1992).
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. H. Hamada,
    2. T. Tsuruo
    , Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 83, 7785–7789 (1986).
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. T. K. Ritchie,
    2. H. Kwon,
    3. W. M. Atkins
    , Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2. J. Biol. Chem. 286, 39489–39496 (2011).
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. T. Tsuruo,
    2. H. Hamada,
    3. S. Sato,
    4. Y. Heike
    , Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies. Jpn. J. Cancer Res. 80, 627–631 (1989).
    OpenUrlCrossRef
  18. ↵
    1. S. G. Aller et al.
    , Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323, 1718–1722 (2009).
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. M. S. Jin,
    2. M. L. Oldham,
    3. Q. Zhang,
    4. J. Chen
    , Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans. Nature 490, 566–569 (2012).
    OpenUrlCrossRefPubMed
  20. ↵
    1. A. Kodan et al.
    , Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog. Proc. Natl. Acad. Sci. U.S.A. 111, 4049–4054 (2014).
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. A. Alam,
    2. J. Kowal,
    3. E. Broude,
    4. I. Roninson,
    5. K. P. Locher
    , Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science 363, 753–756 (2019).
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Y. Kim,
    2. J. Chen
    , Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. Science 359, 915–919 (2018).
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. K. P. Locher
    , Mechanistic diversity in ATP-binding cassette (ABC) transporters. Nat. Struct. Mol. Biol. 23, 487–493 (2016).
    OpenUrlCrossRefPubMed
  24. ↵
    1. J. H. van Wonderen et al.
    , The central cavity of ABCB1 undergoes alternating access during ATP hydrolysis. FEBS J. 281, 2190–2201 (2014).
    OpenUrlCrossRefPubMed
  25. ↵
    1. A. Alam et al.
    , Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1. Proc. Natl. Acad. Sci. U.S.A. 115, E1973–E1982 (2018).
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. P. Szewczyk et al.
    , Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein. Acta Crystallogr. D Biol. Crystallogr. 71, 732–741 (2015).
    OpenUrlCrossRefPubMed
  27. ↵
    1. H. Shen,
    2. F. Y. Lee,
    3. J. Gan
    , Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2). J. Pharmacol. Exp. Ther. 337, 423–432 (2011).
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. K. Nandigama,
    2. S. Lusvarghi,
    3. S. Shukla,
    4. S. V. Ambudkar
    , Large-scale purification of functional human P-glycoprotein (ABCB1). Protein Expr. Purif. 159, 60–68 (2019).
    OpenUrl
  29. ↵
    1. S. Vahedi,
    2. E. E. Chufan,
    3. S. V. Ambudkar
    , Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency. Biochem. Pharmacol. 143, 53–64 (2017).
    OpenUrl
  30. ↵
    1. S. Lusvarghi,
    2. S. V. Ambudkar
    , ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators. Biochem. J. 476, 3737–3750 (2019).
    OpenUrl
  31. ↵
    1. T. W. Loo,
    2. D. M. Clarke
    , Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane. J. Biol. Chem. 274, 35388–35392 (1999).
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. N. L. Pollock et al.
    , Improving the stability and function of purified ABCB1 and ABCA4: The influence of membrane lipids. Biochim. Biophys. Acta 1838, 134–147 (2014).
    OpenUrlCrossRef
  33. ↵
    1. P. Labrie et al.
    , A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators. J. Med. Chem. 49, 7646–7660 (2006).
    OpenUrlCrossRefPubMed
  34. ↵
    1. S. M. Jackson et al.
    , Structural basis of small-molecule inhibition of human multidrug transporter ABCG2. Nat. Struct. Mol. Biol. 25, 333–340 (2018).
    OpenUrlCrossRefPubMed
  35. ↵
    1. W. A. Noyes,
    2. D. B. Forman
    , Aldehyde—amide condensation. I. Reactions between aldehydes and acetamide. J. Am. Chem. Soc. 55, 3493–3494 (1933).
    OpenUrl
  36. ↵
    1. Z. E. Sauna,
    2. S. V. Ambudkar
    , Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes. J. Biol. Chem. 276, 11653–11661 (2001).
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. S. Vasudevan,
    2. T. Tsuruo,
    3. D. R. Rose
    , Mode of binding of anti-P-glycoprotein antibody MRK-16 to its antigen. A crystallographic and molecular modeling study. J. Biol. Chem. 273, 25413–25419 (1998).
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. S. Vahedi et al.
    , Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein. Sci. Rep. 8, 12716 (2018).
    OpenUrl
  39. ↵
    1. R. J. P. Dawson,
    2. K. P. Locher
    , Structure of a bacterial multidrug ABC transporter. Nature 443, 180–185 (2006).
    OpenUrlCrossRefPubMed
  40. ↵
    1. A. Sajid,
    2. S. Lusvarghi,
    3. E. E. Chufan,
    4. S. V. Ambudkar
    , Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1). PLoS One 13, e0204693 (2018).
    OpenUrl
  41. ↵
    1. E. E. Chufan et al.
    , Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1). PLoS One 8, e82463 (2013).
    OpenUrlCrossRefPubMed
  42. ↵
    1. R. Callaghan
    , Providing a molecular mechanism for P-glycoprotein; why would I bother? Biochem. Soc. Trans. 43, 995–1002 (2015).
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Y. Raviv,
    2. H. B. Pollard,
    3. E. P. Bruggemann,
    4. I. Pastan,
    5. M. M. Gottesman
    , Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J. Biol. Chem. 265, 3975–3980 (1990).
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. M. M. Gottesman,
    2. S. V. Ambudkar,
    3. D. Xia
    , Structure of a multidrug transporter. Nat. Biotechnol. 27, 546–547 (2009).
    OpenUrlCrossRefPubMed
  45. ↵
    1. F. J. Sharom
    , Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: Its role in modulating protein function. Front. Oncol. 4, 41 (2014).
    OpenUrlCrossRefPubMed
  46. ↵
    1. R. Dastvan,
    2. S. Mishra,
    3. Y. B. Peskova,
    4. R. K. Nakamoto,
    5. H. S. Mchaourab
    , Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors. Science 364, 689–692 (2019).
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. V. M. Korkhov,
    2. S. A. Mireku,
    3. K. P. Locher
    , Structure of AMP-PNP-bound vitamin B12 transporter BtuCD-F. Nature 490, 367–372 (2012).
    OpenUrlCrossRefPubMed
  48. ↵
    1. I. Manolaridis et al.
    , Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states. Nature 563, 426–430 (2018).
    OpenUrlCrossRef
  49. ↵
    1. E. Crowley,
    2. M. L. O’Mara,
    3. I. D. Kerr,
    4. R. Callaghan
    , Transmembrane helix 12 plays a pivotal role in coupling energy provision and drug binding in ABCB1. FEBS J. 277, 3974–3985 (2010).
    OpenUrlCrossRefPubMed
  50. ↵
    1. E. Crowley et al.
    , Transmembrane helix 12 modulates progression of the ATP catalytic cycle in ABCB1. Biochemistry 48, 6249–6258 (2009).
    OpenUrlCrossRefPubMed
  51. ↵
    1. E. R. Geertsma,
    2. N. A. B. Nik Mahmood,
    3. G. K. Schuurman-Wolters,
    4. B. Poolman
    , Membrane reconstitution of ABC transporters and assays of translocator function. Nat. Protoc. 3, 256–266 (2008).
    OpenUrlCrossRefPubMed
  52. ↵
    1. W. Schaffner,
    2. C. Weissmann
    , A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56, 502–514 (1973).
    OpenUrlCrossRefPubMed
  53. ↵
    1. S. Chifflet,
    2. A. Torriglia,
    3. R. Chiesa,
    4. S. Tolosa
    , A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: Application to lens ATPases. Anal. Biochem. 168, 1–4 (1988).
    OpenUrlCrossRefPubMed
  54. ↵
    1. M. Schorb,
    2. I. Haberbosch,
    3. W. J. H. Hagen,
    4. Y. Schwab,
    5. D. N. Mastronarde
    , Software tools for automated transmission electron microscopy. Nat. Methods 16, 471–477 (2019).
    OpenUrl
  55. ↵
    1. J. Zivanov et al.
    , New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, 1–22 (2018).
    OpenUrlCrossRefPubMed
  56. ↵
    1. S. Q. Zheng et al.
    , MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
    OpenUrlCrossRefPubMed
  57. ↵
    1. K. Zhang
    , Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
    OpenUrlCrossRefPubMed
  58. ↵
    1. P. Emsley,
    2. B. Lohkamp,
    3. W. G. Scott,
    4. K. Cowtan
    , Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
    OpenUrlCrossRefPubMed
  59. ↵
    1. N. W. Moriarty,
    2. R. W. Grosse-Kunstleve,
    3. P. D. Adams
    , Electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D Biol. Crystallogr. 65, 1074–1080 (2009).
    OpenUrlCrossRefPubMed
  60. ↵
    1. A. B. Waight et al.
    , Structural basis of microtubule destabilization by potent auristatin anti-mitotics. PLoS One 11, e0160890 (2016).
    OpenUrl
  61. ↵
    1. P. D. Adams et al.
    , PHENIX: A comprehensive python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
    OpenUrlCrossRefPubMed
  62. ↵
    1. C. J. Williams et al.
    , MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
    OpenUrlCrossRefPubMed
  63. ↵
    1. E. F. Pettersen et al.
    , UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
    OpenUrlCrossRefPubMed
  64. ↵
    1. R. A. Laskowski,
    2. M. B. Swindells
    , LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778–2786 (2011).
    OpenUrlCrossRefPubMed

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

Subscribers, for more details, please visit our Subscriptions FAQ.

Please click here to log into the PNAS submission website.

PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1
Kamil Nosol, Ksenija Romane, Rossitza N. Irobalieva, Amer Alam, Julia Kowal, Naoya Fujita, Kaspar P. Locher
Proceedings of the National Academy of Sciences Oct 2020, 117 (42) 26245-26253; DOI: 10.1073/pnas.2010264117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1
Kamil Nosol, Ksenija Romane, Rossitza N. Irobalieva, Amer Alam, Julia Kowal, Naoya Fujita, Kaspar P. Locher
Proceedings of the National Academy of Sciences Oct 2020, 117 (42) 26245-26253; DOI: 10.1073/pnas.2010264117
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

Article Classifications

  • Biological Sciences
  • Biophysics and Computational Biology
Proceedings of the National Academy of Sciences: 117 (42)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • Abstract
    • Results and Discussion
    • Conclusions
    • Methods
    • Data Availability.
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Setting sun over a sun-baked dirt landscape
Core Concept: Popular integrated assessment climate policy models have key caveats
Better explicating the strengths and shortcomings of these models will help refine projections and improve transparency in the years ahead.
Image credit: Witsawat.S.
Model of the Amazon forest
News Feature: A sea in the Amazon
Did the Caribbean sweep into the western Amazon millions of years ago, shaping the region’s rich biodiversity?
Image credit: Tacio Cordeiro Bicudo (University of São Paulo, São Paulo, Brazil), Victor Sacek (University of São Paulo, São Paulo, Brazil), and Lucy Reading-Ikkanda (artist).
Syrian archaeological site
Journal Club: In Mesopotamia, early cities may have faltered before climate-driven collapse
Settlements 4,200 years ago may have suffered from overpopulation before drought and lower temperatures ultimately made them unsustainable.
Image credit: Andrea Ricci.
Click beetle on a leaf
How click beetles jump
Marianne Alleyna, Aimy Wissa, and Ophelia Bolmin explain how the click beetle amplifies power to pull off its signature jump.
Listen
Past PodcastsSubscribe
Birds nestling on tree branches
Parent–offspring conflict in songbird fledging
Some songbird parents might improve their own fitness by manipulating their offspring into leaving the nest early, at the cost of fledgling survival, a study finds.
Image credit: Gil Eckrich (photographer).

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490